Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

EQS-News: Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business
EQS-News: Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business
EQS-News: Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business
eqs_en 
0 14.03.24
EQS-News: Dermapharm Holding SE builds on success in Q3 2023
EQS-News: Dermapharm Holding SE builds on success in Q3 2023
EQS-News: Dermapharm Holding SE builds on success in Q3 2023
eqs_en 
0 15.11.23
EQS-News: Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall
EQS-News: Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall
EQS-News: Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall
eqs_en 
0 29.08.23
EQS-News: Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
EQS-News: Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
EQS-News: Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
eqs_en 
0 16.08.23
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share
eqs_en 
0 14.06.23
EQS-News: Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit
EQS-News: Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit
EQS-News: Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit
eqs_en 
0 13.06.23
EQS-News: Dermapharm Holding SE: outstanding start to financial year 2023
EQS-News: Dermapharm Holding SE: outstanding start to financial year 2023
EQS-News: Dermapharm Holding SE: outstanding start to financial year 2023
eqs_en 
0 15.05.23
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
eqs_en 
0 28.03.23
EQS-Adhoc: Dermapharm Holding SE: 2022 dividend
EQS-Adhoc: Dermapharm Holding SE: 2022 dividend
EQS-Adhoc: Dermapharm Holding SE: 2022 dividend
eqs_en 
0 22.03.23
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
eqs_en 
0 14.03.23
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma
eqs_en 
0 05.01.23
EQS-News: Dermapharm Holding SE successfully maintains growth trend as planned
EQS-News: Dermapharm Holding SE successfully maintains growth trend as planned
EQS-News: Dermapharm Holding SE successfully maintains growth trend as planned
eqs_en 
0 16.11.22
DGAP-News: Dermapharm Holding SE publishes H1 2022 financial report, confirms outlook for 2022 overall
DGAP-News: Dermapharm Holding SE publishes H1 2022 financial report, confirms outlook for 2022 overall
DGAP-News: Dermapharm Holding SE publishes H1 2022 financial report, confirms outlook for 2022 overall
eqs_en 
0 07.09.22
DGAP-News: Dermapharm Holding SE: Successful first half of 2022 in challenging market environment
DGAP-News: Dermapharm Holding SE: Successful first half of 2022 in challenging market environment
DGAP-News: Dermapharm Holding SE: Successful first half of 2022 in challenging market environment
eqs_en 
0 23.08.22
DGAP-News: Dermapharm commits to acquire the French market leader for herbal medicinal products and food supplements
DGAP-News: Dermapharm commits to acquire the French market leader for herbal medicinal products and food supplements
DGAP-News: Dermapharm commits to acquire the French market leader for herbal medicinal products and food supplements
eqs_en 
0 30.07.22
DGAP-Adhoc: Dermapharm Holding SE: binding offer to acquire Arkopharma Group
DGAP-Adhoc: Dermapharm Holding SE: binding offer to acquire Arkopharma Group
DGAP-Adhoc: Dermapharm Holding SE: binding offer to acquire Arkopharma Group
eqs_en 
0 30.07.22
DGAP-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 2.17 per share
DGAP-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 2.17 per share
DGAP-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 2.17 per share
eqs_en 
0 01.06.22
DGAP-News: Dermapharm Holding SE: excellent start into financial year 2022
DGAP-News: Dermapharm Holding SE: excellent start into financial year 2022
DGAP-News: Dermapharm Holding SE: excellent start into financial year 2022
eqs_en 
0 18.05.22
DGAP-News: Dermapharm Holding SE records best ever year in 2021 - continuous growth in financial year 2022
DGAP-News: Dermapharm Holding SE records best ever year in 2021 - continuous growth in financial year 2022
DGAP-News: Dermapharm Holding SE records best ever year in 2021 - continuous growth in financial year 2022
eqs_en 
0 12.04.22
DGAP-News: Dermapharm Holding SE: 2021 erfolgreichstes Jahr der Firmengeschichte - kontinuierliches Wachstum im Geschäftsjahr 2022
DGAP-News: Dermapharm Holding SE: 2021 erfolgreichstes Jahr der Firmengeschichte - kontinuierliches Wachstum im Geschäftsjahr 2022
DGAP-News: Dermapharm Holding SE: 2021 erfolgreichstes Jahr der Firmengeschichte - kontinuierliches Wachstum im Geschäftsjahr 2022
eqs_de 
0 12.04.22
DGAP-News: Dermapharm Holding SE: Kontinuierliches Wachstum von Konzernumsatz und bereinigtem Konzern-EBITDA in 2022
DGAP-News: Dermapharm Holding SE: Kontinuierliches Wachstum von Konzernumsatz und bereinigtem Konzern-EBITDA in 2022
DGAP-News: Dermapharm Holding SE: Kontinuierliches Wachstum von Konzernumsatz und bereinigtem Konzern-EBITDA in 2022
eqs_de 
0 29.03.22
DGAP-News: Dermapharm Holding SE: Continuous growth of Group revenues and adjusted Group EBITDA in 2022
DGAP-News: Dermapharm Holding SE: Continuous growth of Group revenues and adjusted Group EBITDA in 2022
DGAP-News: Dermapharm Holding SE: Continuous growth of Group revenues and adjusted Group EBITDA in 2022
eqs_en 
0 29.03.22
DGAP-News: Dermapharm Holding SE: Erfolgreichstes Geschäftsjahr der Firmengeschichte - bereinigtes Konzern-EBITDA am oberen Ende der Prognose
DGAP-News: Dermapharm Holding SE: Erfolgreichstes Geschäftsjahr der Firmengeschichte - bereinigtes Konzern-EBITDA am oberen Ende der Prognose
DGAP-News: Dermapharm Holding SE: Erfolgreichstes Geschäftsjahr der Firmengeschichte - bereinigtes Konzern-EBITDA am oberen Ende der Prognose
eqs_de 
0 22.03.22
DGAP-News: Dermapharm Holding SE: Most successful business year in the company's history - Adjusted Group EBITDA at the upper end of the outlook
DGAP-News: Dermapharm Holding SE: Most successful business year in the company's history - Adjusted Group EBITDA at the upper end of the outlook
DGAP-News: Dermapharm Holding SE: Most successful business year in the company's history - Adjusted Group EBITDA at the upper end of the outlook
eqs_en 
0 22.03.22
DGAP-News: Dermapharm successfully acquires C³ Group
DGAP-News: Dermapharm successfully acquires C³ Group
DGAP-News: Dermapharm successfully acquires C³ Group
eqs_en 
0 31.01.22